Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-04-23
1999-07-13
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514558, A61K 3119
Patent
active
059227656
ABSTRACT:
The present invention relates to methods and compositions for the prevention and/or treatment of exercise-induced muscle cramps, stiffness, pain or spasms, using magnesium gluconate alone or in combination with one or more antioxidants or conventional pharmacologic therapy. The invention also relates to inhibition of production of oxygenated molecules, oxygen free radicals and lipid peroxidation.
REFERENCES:
patent: 5002780 (1991-03-01), Bakta et al.
patent: 5260279 (1993-11-01), Greenberg
patent: 5504072 (1996-04-01), Schmidl et al.
patent: 5550166 (1996-08-01), Ostlund et al.
Kleefeld, Ann. Ocul., 1973.
Kleefeld, Bull. Soc. Belg. opht., 1973.
Mansmann, Jr., H.C., "Consider Magnesium Homeostasis" Pediatric Asthma, Allergy& Immunology, 5, pp. 273-279 (1991).
Physicians' Desk Reference, 50th Edition (1996) p. 1005, "Magonate Tablets, Magonate Liquid".
Bardicef, M., et al, 1995, Am. J. Obstet. Gynecol., 172: 1009-1013.
Chen, Y-T, in Internal Medicine, ed. W.N. Kelley, 2270-2273 J.B. Lippincott (1972).
Davies, K.J.A., et al., 1982, Biochem. Biophys. Res. Commun., 107:1198-1205.
Del Maestro, R.F., 1980, Acta. Physiol. Scand., 492 (Suppl.): 153-168.
Deuster, P.A. et al., 1987, Clin. Chem., 33: 529-532.
Deuster, P.A., et al., 1987, J. Appl. Physiol., 62: 545-550.
Elin, R.J., 1987, Clin. Chem., 33: 1965-1970.
Fantone, J.C., et. al., 1982, Am. J. Pathol., 107: 395-418.
Fridovich, I., 1983, Annu. Rev. Pharmacol. Toxicol., 23: 239-257.
Janssen, Y.M., et al., 1993, Lab. Invest., 69: 261-274.
Mak, I.T. et. al., 1990, Biochem. Pharm., 40: 2169-2175.
Mak, I.T., et al., 1995, Biochem. Pharmacol., 50: 1531-1534.
Mak, I.T. & Weglicki, W.B., 1994, Method Enzymol., 234: 620-630.
McDonald, R., et al., 1988, Sports Med., 5: 171-184.
National Research Council, Recommended Dietary Allowances, 10th ed. Washington, D.C.: National Academy Press, 1989, pp. 1, 10-23, 174-205.
Ntoso, K.A and Goldfarb, S., in Internal Medicine ed. J.H. Stein, 2345-2349, Little, Brown and Company, Inc., (1990).
Pao, E.M., Micke, S.J., 1981, Food Technol., 35: 58-69.
Rakel, R.E. ed. Textbook of Family Practice, 3rd ed, W.B. Saunders Co., (1984) 691-692.
Rose, L.I., et. al., 1970, J. Appl. Physiol., 29: 449-451.
Tribble, D.L., et. al., 1987, Hepatology, 7: 377-386.
Rayssiquier, Magnesium Research (1990) 3,2, 93-102.
Fleming Thomas E.
Mansmann, Jr. Herbert C.
Cook Rebecca
Fleming & Company, Pharmaceuticals
LandOfFree
Methods and compositions for the prevention and treatment of mus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the prevention and treatment of mus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the prevention and treatment of mus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276100